NASDAQ, ACET - Adicet Bio Inc

Aceto Corporation, together with its consolidated subsidiaries, are referred to  herein collectively as "Aceto", "Company", "we", "us", and "our" unless the  content indicates otherwise. Aceto was incorporated in 1947 in the State of New  York. We are a global leader in the sourcing, regulatory support, marketing and  distribution of chemically derived pharmaceuticals, biopharmaceuticals,  specialty chemicals and crop protection products. Our business is organized  along product lines into three principal segments: Health Sciences, Chemicals &  Colorants and Crop Protection.  The Health Sciences segment is our largest segment in terms of both sales and  gross profits. Products that fall within this segment include active  pharmaceutical ingredients (API's), pharmaceutical intermediates, nutritionals  and biopharmaceuticals. In fiscal 2007, we entered the market for finished  dosage form generic drugs when we received orders for our first Aceto branded  product, Isoflurane.  ...

Sector:	Consumer Durables
Industry:	Specialty Chemicals
P/E Ratio:	N/A
PEG Ratio:	0.84
EPS:	N/A
DivYield:	2.41
PtB:	0.311
PtS:	0.51
EBITDA:	68.18M
Shares:	82.71M
Market Cap:	51.36M
52wk range:	0.45 - 1.64

216.73.216.229
United States